Medicare Enrolled
Dr. Jennifer Salvitti Davis, M.D
Ophthalmology · Washington, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Salvitti Davis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Salvitti Davis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Salvitti Davis
Dr. Jennifer Salvitti Davis is an ophthalmology specialist in Washington, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Salvitti Davis performed 4,411 Medicare services across 3,574 unique beneficiaries.
Between the years covered by Open Payments, Dr. Salvitti Davis received a total of $10,889 from 47 pharmaceutical and/or device companies across 460 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Salvitti Davis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 19% volume in PA
$10,889 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,411
Medicare services
Top 19% in PA for ophthalmology
3,574
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~210 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
890 | $54 | $110 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
684 | $74 | $152 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
407 | $342 | $1,200 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
377 | $23 | $80 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
308 | $33 | $150 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
267 | $26 | $80 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
254 | $40 | $100 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
224 | $89 | $180 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
151 | $22 | $60 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
146 | $224 | $500 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $36 | $50 |
| Microfluid analysis of tears A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes. |
103 | $22 | $85 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
96 | $145 | $901 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
94 | $11 | $84 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
84 | $616 | $1,900 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
74 | $24 | $100 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
41 | $8 | $25 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
34 | $17 | $82 |
| New patient eye exam, problem focused A focused examination of the visual system performed during a new patient visit. |
29 | $45 | $108 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
28 | $460 | $1,500 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
15 | $12 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.2% high complexity
19.0% medium
71.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,889
Total received (2018-2024)
Avg $1,556/year across 7 years
Top 10% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
460
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,034 (83.0%)
Scientific / Research
Research funding and grants
$1,500 (13.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$300 (2.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$55 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,937
2023
$1,439
2022
$1,358
2021
$1,002
2020
$1,139
2019
$2,792
2018
$1,224
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$390
Bausch & Lomb Americas Inc.
$227
ABBVIE INC.
$206
SUN PHARMACEUTICAL INDUSTRIES INC.
$184
Tarsus Pharmaceuticals, Inc.
$164
Regeneron Healthcare Solutions, Inc.
$114
Alexion Pharmaceuticals, Inc.
$111
Dompe US, Inc.
$79
NEW WORLD MEDICAL,INC.
$69
Harrow Eye, LLC
$65
Thea Pharma Inc.
$59
Ocular Therapeutix, Inc.
$46
Oyster Point Pharma, Inc.
$45
Glaukos Corporation
$42
Astellas Pharma US Inc
$35
RxSight Inc
$26
Surgical Specialties Corporation (us), Inc. (dba Corza Medical)
$20
Genentech USA, Inc.
$20
ANI Pharmaceuticals, Inc.
$19
Apellis Pharmaceuticals, Inc.
$16
Top 3 companies account for 42.5% of 2024 payments
All-time payments by company (2018-2024) ›
Alcon Vision LLC
$2,323
Glaukos Corporation
$1,576
Regeneron Healthcare Solutions, Inc.
$619
Allergan, Inc.
$605
NEW WORLD MEDICAL,INC.
$553
Novartis Pharmaceuticals Corporation
$523
Alcon Laboratories Inc
$427
Bausch & Lomb Americas Inc.
$413
Allergan Inc.
$342
ABBVIE INC.
$329
Sun Pharmaceutical Industries Inc.
$305
SUN PHARMACEUTICAL INDUSTRIES INC.
$264
Bausch & Lomb, a division of Bausch Health US, LLC
$247
Oyster Point Pharma, Inc.
$238
Shire North American Group Inc
$222
Ivantis, Inc
$220
Aerie Pharmaceuticals, Inc.
$179
AbbVie Inc.
$171
Tarsus Pharmaceuticals, Inc.
$164
Kala Pharmaceuticals, Inc.
$117
Alexion Pharmaceuticals, Inc.
$111
Harrow Eye, LLC
$87
Genentech USA, Inc.
$79
Dompe US, Inc.
$79
Eyevance Pharmaceuticals LLC
$66
Thea Pharma Inc.
$59
Sight Sciences, Inc.
$58
Rayner Intraocular Lenses Limited
$49
TissueTech, Inc.
$47
Ocular Therapeutix, Inc.
$46
RxSight Inc
$42
Astellas Pharma US Inc
$35
Akorn, Inc.
$34
Apellis Pharmaceuticals, Inc.
$30
Mallinckrodt Hospital Products Inc.
$29
Carl Zeiss Meditec, Inc.
$25
Surgical Specialties Corporation (us), Inc. (dba Corza Medical)
$20
ANI Pharmaceuticals, Inc.
$19
Carl Zeiss Meditec AG
$19
Horizon Therapeutics plc
$18
EyePoint Pharmaceuticals US, Inc.
$17
Mallinckrodt Enterprises LLC
$16
Omeros Corporation
$15
Alcon Research LLC
$14
GLAUKOS CORPORATION
$14
Marco Ophthalmic, Inc.
$13
NovaBay Pharmaceuticals, Inc.
$12
Top 3 companies account for 41.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · Avenova · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · Centurion · Cequa · Clareon · CyPass · DEXTENZA · DEXYCU · DUREZOL · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Flarex · HYDRUS Microstent · Hydrus · ILEVRO · ILUX · INVELTYS · IOLMaster 500 · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · Izervay · Kahook Dual Blade · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX SM · LUMIGAN · LenSx · Lucentis · Luxor · MIEBO · None Specified · OMNI · OMNI(R) SURGICAL SYSTEM (US) · OPD-III · ORA · OXERVATE · Omidria · PAZEO · PROLENSA · PURIFIED CORTROPHIN GEL · PanOptix · Prokera · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · ReSTOR · Rhopressa · Rocklatan · SIMBRINZA · SUSVIMO · Syfovre · Systane · TEPEZZA · TORIC · TRAVATAN Z · TYRVAYA · Tobradex ST · ULTOMIRIS · VEVYE · VUITY · VYZULTA · Vabysmo · Verion · Wavelight Refractive Suite · XDEMVY · XELPROS · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · Zioptan · iDose · iStent Trabecular Micro-Bypass Stent System · iStent Trabecular Micro-Bypass System Model iS3 · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for ophthalmology in PA.
Geographic Context
Ophthalmologists within 10 mi
107
Per 100K population
51.0
County median income
$77,487
Nearest hospital
WASHINGTON HOSPITAL, THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Salvitti Davis is a mixed practice specialist, with above-average Medicare volume (top 19% in PA), with low-engagement industry engagement in the top 10% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Salvitti Davis experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Salvitti Davis performed 890 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Salvitti Davis receive payments from pharmaceutical companies?
Yes. Dr. Salvitti Davis received a total of $10,889 from 47 companies across 460 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Salvitti Davis's costs compare to other ophthalmologists in Washington?
Dr. Salvitti Davis's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Salvitti Davis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Washington
Browse ophthalmologists in Washington ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in PA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in PA
Which PA ophthalmologists receive the most from drug and device companies.
By company
Alcon Vision LLC Payments to Doctors
See all physicians who received payments from Alcon Vision LLC.
By company
Glaukos Corporation Payments to Doctors
See all physicians who received payments from Glaukos Corporation.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology